Equity (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
|---|
| Equity [Abstract] |
|
| Schedule of Stock by Class |
Preferred stock authorized, issued and outstanding was as follows at both March 31, 2026 and December 31, 2025: | | | | | | | | | | | | | | | | Series | | Shares
Authorized | | Shares Issued and
Outstanding | | Floating Rate Non-Cumulative Preferred Stock, Series A | | 27,600,000 | | | 24,000,000 | | | 5.875% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series D | | 500,000 | | | 500,000 | | | 5.625% Non-Cumulative Preferred Stock, Series E | | 32,200 | | | 32,200 | | | 4.75% Non-Cumulative Preferred Stock, Series F | | 40,000 | | | 40,000 | | | Series A Junior Participating Preferred Stock | | 10,000,000 | | | — | | | Not designated | | 161,827,800 | | | — | | | Total | | 200,000,000 | | | 24,572,200 | |
|
| Dividends Declared |
The per share and aggregate dividends declared for MetLife, Inc.’s preferred stock were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | 2026 | | 2025 | | Series | | Per Share | | Aggregate | | Per Share | | Aggregate | | (In millions, except per share data) | | A | | $ | 0.315 | | | $ | 7 | | | $ | 0.355 | | | $ | 9 | | | D | | $ | 29.375 | | | 15 | | | $ | 29.375 | | | 15 | | | E | | $ | 351.563 | | | 11 | | | $ | 351.563 | | | 11 | | | F | | $ | 296.875 | | | 12 | | | $ | 296.875 | | | 12 | | G (1) | | $ | — | | | — | | | $ | 19.250 | | | 19 | | | Total | | | | $ | 45 | | | | | $ | 66 | |
__________________ (1)Dividends were paid through the dividend payment date of September 15, 2025, when all outstanding shares of MetLife, Inc.’s 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G were redeemed.
|
| Class of Treasury Stock |
MetLife, Inc. announced that its Board of Directors authorized common stock repurchases as follows: | | | | | | | | | | | | | | | | Announcement Date | | Authorization Amount | | Authorization Remaining at March 31, 2026 (1) | | | (In millions) | | April 30, 2025 | | $ | 3,000 | | | $ | 1,317 | | | May 1, 2024 | | $ | 3,000 | | | $ | — | |
__________________ (1)The Inflation Reduction Act, signed into law on August 16, 2022, imposes a one percent excise tax, net of any allowable offsets, on certain corporate stock buybacks made after December 31, 2022. The authorization remaining at March 31, 2026 does not reflect the applicable excise tax payable.
|
| Components of Accumulated Other Comprehensive Income (Loss) |
Information regarding changes in the balances of each component of AOCI attributable to MetLife, Inc. was as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months
Ended
March 31, 2026 | | | Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1) | | Deferred
Gains (Losses)
on Derivatives | | FPBs Discount Rate Remeasurement Gains (Losses) | | MRBs Instrument- Specific Credit Risk Remeasurement Gains (Losses) | | Foreign
Currency
Translation
Adjustments | | Defined
Benefit
Plans
Adjustment | | Total | | | (In millions) | | Balance, beginning of period | | $ | (15,614) | | | $ | (1,588) | | | $ | 6,871 | | | $ | (97) | | | $ | (6,263) | | | $ | (1,393) | | | $ | (18,084) | | | OCI before reclassifications | | (5,098) | | | 499 | | | 2,722 | | | 52 | | | (117) | | | — | | | (1,942) | | | Deferred income tax benefit (expense) | | 1,164 | | | (119) | | | (592) | | | (11) | | | (23) | | | — | | | 419 | | | AOCI before reclassifications, net of income tax | | (19,548) | | | (1,208) | | | 9,001 | | | (56) | | | (6,403) | | | (1,393) | | | (19,607) | | | Amounts reclassified from AOCI | | 226 | | | 246 | | | — | | | — | | | — | | | 24 | | | 496 | | | Deferred income tax benefit (expense) | | (58) | | | (53) | | | — | | | — | | | — | | | (5) | | | (116) | | | Amounts reclassified from AOCI, net of income tax | | 168 | | | 193 | | | — | | | — | | | — | | | 19 | | | 380 | | | | | | | | | | | | | | | | | | Balance, end of period | | $ | (19,380) | | | $ | (1,015) | | | $ | 9,001 | | | $ | (56) | | | $ | (6,403) | | | $ | (1,374) | | | $ | (19,227) | | | | | | | | | | | | | | | | | | | Three Months
Ended
March 31, 2025 | | | Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1) | | Deferred
Gains (Losses)
on Derivatives | | FPBs Discount Rate Remeasurement Gains (Losses) | | MRBs Instrument- Specific Credit Risk Remeasurement Gains (Losses) | | Foreign
Currency
Translation
Adjustments | | Defined
Benefit
Plans
Adjustment | | Total | | | (In millions) | Balance at December 31, 2024 | | $ | (19,402) | | | $ | 370 | | | $ | 6,529 | | | $ | (71) | | | $ | (7,170) | | | $ | (1,442) | | | $ | (21,186) | | Cumulative effects of change in accounting principles for equity method investees at January 1, 2025 | | 70 | | | — | | | (1,144) | | | — | | | — | | | — | | | (1,074) | | | OCI before reclassifications | | 2,204 | | | 217 | | | 48 | | | 51 | | | 140 | | | 2 | | | 2,662 | | | Deferred income tax benefit (expense) | | (388) | | | (105) | | | (99) | | | (11) | | | 45 | | | — | | | (558) | | | AOCI before reclassifications, net of income tax | | (17,516) | | | 482 | | | 5,334 | | | (31) | | | (6,985) | | | (1,440) | | | (20,156) | | | Amounts reclassified from AOCI | | 241 | | | (379) | | | — | | | — | | | — | | | 31 | | | (107) | | | Deferred income tax benefit (expense) | | (54) | | | 76 | | | — | | | — | | | — | | | (7) | | | 15 | | | Amounts reclassified from AOCI, net of income tax | | 187 | | | (303) | | | — | | | — | | | — | | | 24 | | | (92) | | | | | | | | | | | | | | | | | | Balance, end of period | | $ | (17,329) | | | $ | 179 | | | $ | 5,334 | | | $ | (31) | | | $ | (6,985) | | | $ | (1,416) | | | $ | (20,248) | |
__________________ (1)Primarily unrealized gains (losses) on fixed maturity securities.
|
| Reclassification out of Accumulated Other Comprehensive Income (Loss) |
Information regarding amounts reclassified out of each component of AOCI was as follows: | | | | | | | | | | | | | | | | | | | | | | | Three Months
Ended
March 31, | | | | | 2026 | | 2025 | | | | AOCI Components | | Amounts Reclassified from AOCI | | Consolidated Statements of
Operations and
Comprehensive Income (Loss)
Locations | | | (In millions) | | | | Unrealized investment gains (losses): | | | | | | | | Unrealized investment gains (losses) | | $ | (220) | | | $ | (285) | | | Net investment gains (losses) | | Unrealized investment gains (losses) | | (1) | | | — | | | Net investment income | | Unrealized investment gains (losses) | | (5) | | | 44 | | | Net derivative gains (losses) | | Unrealized investment gains (losses), before income tax | | (226) | | | (241) | | | | Income tax (expense) benefit | | 58 | | | 54 | | | | | Unrealized investment gains (losses), net of income tax | | (168) | | | (187) | | | | | Deferred gains (losses) on derivatives - cash flow hedges: | | | | | | | Interest rate derivatives | | 1 | | | 17 | | | Net investment income | Interest rate derivatives | | 1 | | | — | | | Net investment gains (losses) | | | | | | | | Foreign currency exchange rate derivatives | | 1 | | | 2 | | | Net investment income | Foreign currency exchange rate derivatives | | (249) | | | 360 | | | Net investment gains (losses) | | | | | | | | | | | | | | | | | | | | | | Gains (losses) on cash flow hedges, before income tax | | (246) | | | 379 | | | | Income tax (expense) benefit | | 53 | | | (76) | | | | Gains (losses) on cash flow hedges, net of income tax | | (193) | | | 303 | | | | Defined benefit plans adjustment: (1) | | | | | | | Amortization of net actuarial gains (losses) | | (27) | | | (34) | | | | Amortization of prior service (costs) credit | | 3 | | | 3 | | | | Amortization of defined benefit plan items, before income tax | | (24) | | | (31) | | | | Income tax (expense) benefit | | 5 | | | 7 | | | | Amortization of defined benefit plan items, net of income tax | | (19) | | | (24) | | | | Total reclassifications, net of income tax | | $ | (380) | | | $ | 92 | | | |
__________________ (1)These AOCI components are included in the computation of net periodic benefit costs. See Note 15.
|